ImpediMed Limited
IPDQF
$0.01
-$0.02-63.69%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.87M | -3.79M | -3.63M | -3.73M | -3.32M |
| Total Depreciation and Amortization | -523.70K | -512.80K | 719.10K | 739.40K | -191.80K |
| Total Amortization of Deferred Charges | 1.28M | 1.25M | -- | -- | 550.60K |
| Total Other Non-Cash Items | 152.50K | 149.30K | 542.20K | 557.50K | -892.60K |
| Change in Net Operating Assets | 605.00K | 592.50K | -- | -- | 223.10K |
| Cash from Operations | -2.36M | -2.31M | -2.37M | -2.44M | -3.63M |
| Capital Expenditure | -19.20K | -18.80K | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -108.30K | -106.00K | -192.60K | -198.00K | -472.20K |
| Cash from Investing | -127.50K | -124.80K | -192.60K | -198.00K | -472.20K |
| Total Debt Issued | 7.98M | 7.98M | -- | -- | -- |
| Total Debt Repaid | -100.00K | -100.00K | -111.00K | -111.00K | -120.00K |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -951.50K | -951.50K | -- | -- | 0.00 |
| Cash from Financing | 4.44M | 4.35M | -72.30K | -74.40K | -79.10K |
| Foreign Exchange rate Adjustments | -514.40K | -503.70K | 374.40K | 384.90K | 136.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.44M | 1.41M | -2.26M | -2.32M | -4.04M |